These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25498216)

  • 1. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
    Kissa M; Tsatsaronis G; Schroeder M
    Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Literature mining, ontologies and information visualization for drug repurposing.
    Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
    Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E; Shin M
    Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
    Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
    Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature-based prediction of novel drug indications considering relationships between entities.
    Jang G; Lee T; Lee BM; Yoon Y
    Mol Biosyst; 2017 Jun; 13(7):1399-1405. PubMed ID: 28581007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
    Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
    J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
    Wang YY; Cui C; Qi L; Yan H; Zhao XM
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-based inference methods for drug repositioning.
    Chen H; Zhang H; Zhang Z; Cao Y; Tang W
    Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative literature and data mining to rank disease candidate genes.
    Wu C; Zhu C; Jegga AG
    Methods Mol Biol; 2014; 1159():207-26. PubMed ID: 24788269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
    Sun P; Guo J; Winnenburg R; Baumbach J
    Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MD-Miner: a network-based approach for personalized drug repositioning.
    Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug indications based on chemical interactions and chemical similarities.
    Huang G; Lu Y; Lu C; Zheng M; Cai YD
    Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing based on drug-drug interaction.
    Zhou B; Wang R; Wu P; Kong DX
    Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.